The largest database of trusted experimental protocols

Ifn γ elispot set

Manufactured by BD
Sourced in United States

The IFN-γ ELISPOT Set is a laboratory equipment used for the detection and quantification of interferon-gamma (IFN-γ) secreting cells. It provides a sensitive and reliable method for measuring the cell-mediated immune response.

Automatically generated - may contain errors

4 protocols using ifn γ elispot set

1

Measuring Vaccine-Induced IFN-γ Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Responses induced by vaccination were measured using IFN-γ ELISPOT Set (BD-Biosciences). Splenocytes (5 × 105/well) were stimulated with OVA(257-264), OVA (323-339), AH1-A5 or ELA (10 μM) for 24 hours at 37 °C and the number of spot-forming cells was counted using an ImmunoSpot automated counter. Non-stimulated cells were used as controls.
+ Open protocol
+ Expand
2

Quantifying Vaccine-Induced Cellular Immunity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Responses induced by vaccination were measured by using an IFN-γ ELISPOT Set (BD-Biosciences, Franklin Lakes, NJ, USA). Briefly, splenocytes (8 × 105 cells/well) were cultured in ELISPOT plates and stimulated with OVA or GPC3 CD4/CD8 epitope peptides (10 μg/mL), OVA protein (10 μg/mL), GPC3 peptide pools (1 μg/mL of each peptide) or irradiated tumor cells (8 × 104 cells/well). One day later plates were washed, developed and spot-forming cells were counted automatically.
+ Open protocol
+ Expand
3

T Cell Activation Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Most T cell responses were evaluated by using an IFN-γ ELISPOT Set from BD-Biosciences as described (30 (link)). In brief, spleens were removed, homogenized, erythrocytes were lysed and cells (8×105/well) were stimulated with different peptide concentrations (10-0.01 μM). To analyze recognition of neoantigen-presenting tumor cells, irradiated (200 Gy) MC703 cells (8×104 cells/well), transduced with retroviruses encoding neoantigens or with control vector, were cocultured with splenocytes (8×105/well) obtained from immunized mice. In all cases, 24 h later ELISPOT plates were developed and spot-forming cells were counted with an ImmunoSpot automated counter using Immunospot Image Acquisition 4.5 and Immunospot 3 software.
In some cases, T cell activation was determined by flow cytometry. Splenocytes were stimulated for 4 hours with peptides (10 μM) in the presence of GolgiStop and GolgiPlug (BD-Biosciences) and antiCD107a-FITC (BD-Pharmingen). Next, they were stained with anti-CD3ϵ-Percp-Cy5, CD4-FITC and CD8-BV421 (BioLegend). Then, cells were fixed and permeabilized with BD Cytofix/Cytoperm™ Fixation/Permeablization Kit and intracellularly stained with IFNγ-PE and TNFα-BV510 antibodies (BioLegend). Dead cells were excluded from the analysis using Maleimide (PromoKine). Samples were acquired with a Cytoflex cytometer (Beckman Coulter) and data analyzed using FlowJo software.
+ Open protocol
+ Expand
4

ZIKV-Specific T Cell Response Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cellular response was assessed in spleens through ELISPOT using the IFN-γ ELISPOT set (BD Biosciences, USA) as previously described (26 (link)) 0.5x106 cells/well were stimulated with 2 µg/mL of recombinant ZIKV E protein (Native Antigen, UK). The anti-CD3 and anti-CD28 antibodies (1 µg/mL each) (BD Bioscience, USA) were used as positive control. Unstimulated cells were used as baseline. Spots were quantified using AID iSpot FluoroSpot Reader System and AID EliSpot Version 7.0 software (AID-Autoimmun Diagnostika GMBH, Germany). Assays were performed in duplicate, baseline values were subtracted from all samples, and the results were expressed as the average number of spots forming cells (SFCs) per 106 cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!